APA (7th ed.) Citation

Kanyawan Tiwattanon, Shobana John, Shobana John, Napatrupron Koomdee, Napatrupron Koomdee, Pimonpan Jinda, . . . Chonlaphat Sukasem. (2022). Implementation of HLA-B*15: 02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Kanyawan Tiwattanon, et al. Implementation of HLA-B*15: 02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Kanyawan Tiwattanon, et al. Implementation of HLA-B*15: 02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand. Frontiers Media S.A., 2022.